- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03966391
Effectiveness of CARD for Improving School-Based Immunizations
Effectiveness of a Multi-faceted Knowledge Translation Intervention (The CARD System) for School Based Immunizations: a Cluster Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
The investigators developed a multi-faceted knowledge translation intervention called The CARD System to provide a framework for delivering vaccinations at school that integrates evidence-based strategies to mitigate pain, fear and fainting and promotes a student-centred approach to vaccination. CARD addresses 2 components of the vaccination delivery program: 1) pre-vaccination day preparation and 2) vaccination day activities. In a small controlled clinical trial in a public health unit in Niagara, Ontario, the investigators demonstrated benefits of CARD on student symptoms during vaccination, including fear, and dizziness-precursor of fainting, and satisfaction with CARD by all stakeholder groups (students, public health staff, school staff and parents). This study will evaluate CARD in a large cluster trial in Calgary, Alberta. This trial is the final phase of a 3-phase project, whereby the first 2 phases involve developing an implementation plan for the local context and evaluating feasibility of implementation.
Eight community health centres that provide vaccination services to schools in their regions will be randomized in a 1:1 ratio to CARD or control (usual practices). Data will be collected for vaccination services carried out in grade 6 and grade 9 students in participating schools for the academic year 2019-2020.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2W 3N2
- Alberta Health Services Public Health - Calgary Zone
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- grade 6 and 9 students eligible for vaccination at school
- public health staff in community health centre involved in the study
- school staff in a participating school involved in school vaccination
- parent of a student eligible for vaccination at school
Exclusion Criteria:
- unable to understand and read English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CARD (multi-faceted knowledge translation intervention)
CARD will be integrated into the school vaccination program.
This includes pre-vaccination day preparation (e.g., planning of clinic spaces, student and school staff education about CARD) and vaccination day activities (e.g., clinic set-up, processes for triaging students, implementing pain/ fear/fainting mitigation interventions from CARD during vaccination)
|
The intervention consists of education of relevant stakeholders of best practices and integration of best practices into the vaccination delivery program
Other Names:
|
No Intervention: Control (standard care)
There are no specific procedures being undertaken to plan or execute clinics.
Usual practices will be instituted (i.e., no education specific to CARD, nor clinic set-up or execution to incorporate interventions for pain, fear or fainting)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Student fear
Time Frame: within 5 minutes after vaccination
|
student self-reported fear during vaccination, rated on a 0-10 scale
|
within 5 minutes after vaccination
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Student pain
Time Frame: within 5 minutes after vaccination
|
student self-reported pain during vaccination, rated on a 0-10 scale
|
within 5 minutes after vaccination
|
Student dizziness
Time Frame: within 5 minutes after vaccination
|
student self-reported dizziness during vaccination, rated on a 0-10 scale
|
within 5 minutes after vaccination
|
Student fainting
Time Frame: within 1 hour after vaccination
|
student fainting during vaccination, yes/no, as assessed by immunizer
|
within 1 hour after vaccination
|
Student post-immunization stress-related responses
Time Frame: within 1 hour after vaccination
|
student post-immunization stress-related responses, yes/no, as assessed by immunizer using the WHO Immunization Stress Responses Criteria
|
within 1 hour after vaccination
|
Utilization of coping strategies
Time Frame: within 5 minutes after vaccination
|
use of individual coping strategies during vaccination (distraction, topical anesthetic, privacy, support person, deep breathing, muscle tension), yes/no, as assessed by immunizer using Documentation checklist
|
within 5 minutes after vaccination
|
Uptake of vaccination
Time Frame: by end of school year
|
proportion of students vaccinated (overall and for each vaccine)
|
by end of school year
|
Compliance with CARD
Time Frame: within 3 months after vaccination clinics
|
percent compliance with CARD implementation as assessed by implementers using a CARD compliance checklist.
This information will be supplemented with information from focus groups with implementers and study notes, as well as focus groups with other stakeholder groups (students, parents, school staff).
|
within 3 months after vaccination clinics
|
Implementation success of CARD
Time Frame: within 3 months after vaccination clinics
|
perceptions of implementation success of CARD program delivery as reported by CARD implementers (primary targets) using the CARD Global Impression Checklist, individual questions (5-point likert scale, higher number represents better outcome).
This information will be supplemented with information from focus groups with implementers and study notes
|
within 3 months after vaccination clinics
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anna Taddio, PhD, University of Toronto
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 036893
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccine Adverse Reaction
-
PT Bio FarmaCenter for Child Health Universitas Gadjah Mada (CCH-PRO UGM; Cipto Mangunkusumo... and other collaboratorsRecruitingVaccine Adverse Reaction | Vaccine ReactionIndonesia
-
Sungkyunkwan UniversityGovernment-wide R&D Fund project for infectious disease researchUnknownPneumococcal Vaccine Adverse ReactionKorea, Republic of
-
Persephone BiosciencesTerminatedVaccine Adverse Reaction | Vaccine Response ImpairedUnited States
-
PT Bio FarmaHasan Sadikin General HospitalNot yet recruitingDiphtheria Vaccine Adverse Reaction | Tetanus Vaccine Adverse Reaction | Pertussis Vaccine Adverse Reaction | Haemophilus Influenzae Type B Vaccine Adverse Reaction | Hepatitis B Vaccine Adverse ReactionIndonesia
-
Bandim Health ProjectResearch Center for Vitamins and VaccinesCompletedVaccine Adverse Reaction | Vaccine Reaction | Infant Mortality | Heterologous Immunity | Infant Morbidity | Trained ImmunityGuinea-Bissau
-
Sun XinActive, not recruitingVaccine Adverse ReactionChina
-
University of TorontoTerminatedVaccine Adverse Reaction | Fear | Vaccination; ComplicationsCanada
-
University of AarhusCompleted
-
University Hospital, CaenCompleted
-
Zagazig UniversityCompletedVaccine Adverse Reaction | SeroconversionEgypt
Clinical Trials on Multi-faceted knowledge translation intervention
-
University of TorontoTerminatedVaccine Adverse Reaction | Fear | Vaccination; ComplicationsCanada
-
University of TorontoUnknownImmunisation Anxiety Related ReactionCanada
-
Toronto Rehabilitation InstituteMcGill UniversityUnknown
-
University of Lausanne HospitalsCompletedDiabetes | Rheumatoid ArthritisSwitzerland
-
University of ManitobaUniversity of British Columbia; McGill University; University of Toronto; University... and other collaboratorsCompleted
-
Dignitas InternationalUniversity of Toronto; Ministry of Health and Population, MalawiCompleted
-
Sunnybrook Health Sciences CentreScarborough General Hospital; Michael Garron Hospital; York Central Hospital,... and other collaboratorsCompleted
-
University of MichiganCommunity Foundation of Greater FlintActive, not recruitingAnterior Cruciate Ligament Injuries | Lower Extremity ProblemUnited States
-
Montreal General HospitalSanofi; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche...CompletedAcute Coronary Syndromes
-
University of PisaNational Health and Medical Research Council, Australia; European CommissionEnrolling by invitation